Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients

Gonzalez-Hormazabal, Patricio; Arenas, Alex; Serrano, Carolina; Pizarro, Margarita; Fuentes-Lopez, Eduardo; Arnold, Jorge; Berger, Zoltan; Musleh, Maher; Valladares, Hector; Lanzarini, Enrique; Jara, Lilian; Castro, V. Gonzalo; Camargo, M. Constanza; Riquelme, Arnoldo

Abstract

Background. Treatments for Helicobacter pylori (H. pylori) eradication include the use of antibiotics and a proton-pump inhibitor. Antibiotic resistance is a major concern for two drugs: levofloxacin and clarithromycin. The aim was to determine the prevalence of levofloxacin resistance (LevoR) and clarithromycin resistance (ClaR) in an urban population in Santiago, Chile.

Más información

Título según WOS: Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients
Título de la Revista: ARCHIVES OF MEDICAL RESEARCH
Volumen: 52
Número: 5
Editorial: Elsevier Science Inc.
Fecha de publicación: 2021
Página de inicio: 529
Página final: 534
DOI:

10.1016/J.ARCMED.2021.01.011

Notas: ISI